๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This double-blind, randomized, placebo-controlled, parallel-group, multicen...
Status
Recruiting
Location
Oregon Health & Science University
Start Date
2026-03-30
Trial ID
NCT07301320
Treatments Being Tested
The purpose of this study is to determine whether treatment of unexplained ...
Status
Terminated
Location
Lakeview Medical Research
Start Date
2012-03
Trial ID
NCT01506726
Aim of prospective randomized a placebo controlled study is to prove that i...
Status
Completed
Location
Faculty Hospital Bulovka
Start Date
2008-07
Trial ID
NCT01524081
Treatments Being Tested
A dose escalation study to assess the efficacy and safety of Clavulanic Aci...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2023-05-03
Trial ID
NCT05562349
Treatments Being Tested
Low back pain is a common cause of visit to emergency department. It is not...
Status
Completed
Location
Montefiore Medical Center
Start Date
2016-03
Trial ID
NCT02665286
Treatments Being Tested
The objectives of this study is to examine the Safety and E๏ฌcacy of black y...
Status
Completed
Location
198 Hospital
Start Date
2017-04-01
Trial ID
NCT03717714
Treatments Being Tested
Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-05
Trial ID
NCT00924573
Treatments Being Tested
The purpose of this study is to learn more about how the kidneys control th...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-01
Trial ID
NCT00438932
Treatments Being Tested
This is a randomized, double-blind pilot study of Nicotinamide Riboside (NR...
Status
Terminated
Location
UPMC Children's Hospital of Pittsburgh
Start Date
2024-02-28
Trial ID
NCT05561738
Treatments Being Tested
The immediate release (IR) formulation of retigabine has been shown to be s...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-08-29
Trial ID
NCT01648101
Treatments Being Tested